A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus.

Trial Profile

A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jan 2010

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Uterine leiomyoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 08 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top